F.D.A. Panel Supports Avastin to Treat Brain Tumor
Wednesday, April 1, 2009 - 01:21
in Health & Medicine
Preliminary studies of a blockbuster drug from Roche’s Genentech unit are strong enough to speed its approval for brain cancer, federal cancer experts said.